- ECHA
- Konsultationen
- Konsultation betreffend Ausnahmen zu den Ausschlusskriterien
- Bisherige Konsultationen betreffend Ausnahmen zu den Ausschlusskriterien
Bisherige Konsultationen betreffend Ausnahmen zu den Ausschlusskriterien
Bisherige Konsultationen betreffend Ausnahmen zu den Ausschlusskriterien
The closed consultations on the derogations to the exclusion criteria as laid down in Article 5(2) of the BPR are listed in the table below.
There are currently no ongoing consultations.
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) (originally notified as MBO) | 2, 6, 11, 12, 13 | - | - | 04/09/2017 | 04/11/2017 | Details |
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 1:1) (originally notified as HPT) | 2, 6, 11, 13 | - | - | 04/09/2017 | 04/11/2017 | Details |
Creosote | PT08 | 232-287-5 | 8001-58-9 | 29/01/2021 | 30/03/2021 | Details |
Cholecalciferol | 14 | 200-673-2 | 67-97-0 | 01/02/2018 | 01/04/2018 | Details |
2,2-dibromo-2-cyanoacetamide; [DBNPA] | 4 | 233-539-7 | 10222-01-2 | 11/10/2019 | 10/12/2019 | Details |
2,2-dibromo-2-cyanoacetamide (DBNPA) | PT 6 | 233-539-7 | 10222-01-2 | 03/11/2023 | 04/01/2024 | Details |
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 8 | 262-104-4 | 60207-90-1 | 17/06/2022 | 15/08/2022 | Details |